The effects of radiotherapy on the immune system of patients with nasopharyngeal carcinoma.
We report on 123 patients with nasopharyngeal carcinoma whose immune status was measured at the time of diagnosis, the day radiotherapy was completed, and then 2-3 months and 6-8 months after completion of radiotherapy. Immunological tests performed included the lymphocyte transformation test, the erythrocyte-rosette formation test (ERFT), the 29 degrees C erythrocyte-rosette formation test (29 degrees C ERFT), lymphocyte counts (lymphocytes/mm3 and percentage of lymphocytes), levels of serum immunoglobulins (IgG, IgA, IgM), complement (C3) and circulating immune complexes (CIC), the antinuclear antibody test and a skin test using phytohaemagglutinin (PHA). There were statistically significant differences in all tests (except C3) between patients and normal controls. Marked differences were seen in the lymphocyte count, ERFT, and 29 degrees C ERFT after radiotherapy (p less than 0.01). The diameters of induration of the PHA skin tests were less than those before radiotherapy (p less than 0.01). There were higher incidences of recurrence and metastases in the patients with high levels of CIC and low numbers of lymphocytes in the peripheral blood after radiotherapy. Cellular immunity remained at a low level 8 months after radiotherapy.
Hu
D E
DE
Fujian Provincial Tumour Hospital, People's Republic of China.
Ling
X S
XS
Hu
J
J
Li
B L
BL
Wang
X F
XF
Shen
Y G
YG
Ye
J
J
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D003176:Complement C3 / Q000528:radiation effects; D005260:Female; D006801:Humans; D007107:Immune System / Q000528:radiation effects*; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count / Q000528:radiation effects; D008213:Lymphocyte Activation / Q000528:radiation effects; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy*; D012397:Rosette Formation
D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D003176:Complement C3; D007136:Immunoglobulins